Drawing for EMERGING THERAPY SOLUTIONS

USPTO serial 88051774

EMERGING THERAPY SOLUTIONS

Reviewed by CopyMark Law Group

Reg. 5864468Status 701Registered
Filing date
Status date
Registration date
Sep 17, 2019
Examiner
SANTOMARTINO, MARTHA L
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with EMERGING THERAPY SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia A. Moyer

Cynthia A. Moyer Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500MINNEAPOLIS, MN 55402

Goods and services

ClassDescriptionStatusFirst use
035Business management and consulting services for the health care industry, namely, business management of cell, gene and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks; business administration of cell, gene and other complex therapy programsACTIVEAug 31, 2017
036Financial consultation to healthcare providers, namely, providing assistance in obtaining reimbursement of health care expenses related to cell, gene and other complex therapiesACTIVEAug 31, 2017
044Consulting services in the field of medical care, namely, developing medical treatment policies related to cell, gene, and other complex therapies; medical information services related to cell, gene and other complex therapiesACTIVEAug 31, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 25, 2026NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 25, 20268.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jun 25, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 17, 2026ES8RTEAS SECTION 8 RECEIVED—
Sep 17, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 17, 2019R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Aug 12, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 5, 2019CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Jul 11, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 11, 2019AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Jul 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2019IUAAUSE AMENDMENT ACCEPTED—
Jul 10, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 28, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 28, 2019ALIEASSIGNED TO LIE—
May 24, 2019AUPCAMENDMENT TO USE PROCESSING COMPLETE—
May 24, 2019IUAFUSE AMENDMENT FILED—
May 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 23, 2019EAAUTEAS AMENDMENT OF USE RECEIVED—
Nov 26, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2018DOCKASSIGNED TO EXAMINER—
Jul 30, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance